Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
BioMarin Pharmaceuticals, Inc. (NQ: BMRN)
57.21 USD  UNCHANGED
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 58.30
Bid (Size) 37.01 (100)
Ask (Size) 60.00 (1000)
Prev. Close 57.21
Today's Range 57.16 - 58.60
52wk Range 35.99 - 71.56
Shares Outstanding 139,010,175
Dividend Yield N/A
Top News
More News
CORRECTED-UPDATE 1-Niche drugmaker ViroPharma attracts takeover interest - sources
June 19, 2013
(In June 17 item, corrects in 3rd paragraph to show that ViroPharma is 19 years old) Read More
category companyNews
from Reuters: Company News
UPDATE 1-Niche drugmaker ViroPharma attracts takeover interest -sources
June 17, 2013
NEW YORK, June 17 (Reuters) - ViroPharma Inc, a drug maker specializing in rare diseases, is attracting preliminary acquisition interest from several pharmaceutical companies, according to three people... Read More
category companyNews
from Reuters: Company News

More News
Read More
Orphan drugmaker ViroPharma attracts takeover interest -sources
June 17, 2013
category companyNews
from Reuters: Company News
StockCall Study on BMRN, DCTH, ASTX, and AKRX
June 14, 2013
from ACCESSWIRE
Ongoing Clinical Trials Reveal Groundbreaking Results - Research Report on Alexion, BioMarin, Onyx, Questcor, and ImmunoGen
June 14, 2013
from PR Newswire
UPDATE: Jean-Jacques Bienaime, CEO of BioMarin, to Present at the Goldman Sachs Global Healthcare Conference
June 06, 2013
from GlobeNewswire News Releases
BioMarin to Present at the Goldman Sachs Global Healthcare Conference
June 06, 2013
from GlobeNewswire News Releases
Critical Alerts For General Motors, SAP, Blackberry, BioMarin Pharmaceutical, and Trimble Navigation Released By InvestorsObserver
June 05, 2013
from PR Newswire
BioMarin Initiates Phase 3 Trial for PEG-PAL for the Treatment of PKU
June 05, 2013
from GlobeNewswire News Releases
Upgrade Alert for BioMarin Pharmaceutical (BMRN)
June 04, 2013
from Comtex SmarTrend® News Briefs
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here